ADMA Biologics Highlights $510M+ 2025 Revenue, Raises 2027 Outlook at JPM Healthcare Conference
ADMA Biologics (NASDAQ:ADMA) used its presentation at the J.P. Morgan Healthcare Conference to highlight a revenue pre-announcement for 2025, discuss manufacturing and supply chain developments, and...